Treatment of anal human papillomavirus-associated disease: A long term outcome study

International Journal of STD and AIDS

Volumn 19, Issue 7, 2008, Pages 445-449

  Nathan, Mayura ^a   Hickey, N ^a   Mayuranathan, L ^a   Vowler, S L ^b   Singh, N ^c  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Anal cancer screening; Anal intraepithelial neoplasia; Anal warts; Laser treatment

Indexed keywords

ANTIRETROVIRUS AGENT; IMIQUIMOD;

ADULT; ANAL INTRAEPITHELIAL NEOPLASIA; ANUS DISEASE; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; WART VIRUS;

ADULT; ANUS DISEASES; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; WARTS;

EID: 47949083758     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007290     Document Type: Article

References (25)

1. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993;306:419-22
2. Melbye M, Rabkin CS, Frisch M, et al. Changing patterns of anal cancer incidence in the USA, period 1940-89. Am J Epidemiol 1994;139:772-80
3. Cress RD, Holly EA. Incidence of anal cancer in California: increases incidence among men in San Francisco, 1973-1999. Prev Med 2003;36:555-60
4. Bower M, Powles T, Newsom-Davis T, et al. HIV associated anal cancer - has HAART reduced incidence or improved the outcome? J Acquir Immune Defic Syndr 2004;37:1563-5
5. Holm R, Tanum G, Karlsen F, et al. Prevalence and physical state of human papillomavirus DNA in anal carcinomas. Mod Pathol 1994;7:449-53
6. Frisch M, Fenger C, van den Brule AJC, et al. Variants of squamous cell carcinomas of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59:753-7
7. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immune suppression and HIV among homosexual men. AIDS 1993;7:43-9
8. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV) - positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7
9. Critchlow CW, Holmes KK, Wood R, et al. Association of human immunodeficiency virus anal human papillomavirus infection among homosexual men. Arch Intern Med 1992;152:1673-6
10. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases and the incidence of anal cancer. N Engl J Med 1987;317:973-7
11. Holly EA, Whittemore AS, Aston DA, et al. Anal cancer incidence: genital warts, anal fissure or fistula, haemorrhoids and smoking. J Natl Cancer Inst 1989;81:1726-31
12. Cologuhoun P, Efran J, Eze G, et al. The incidence of subclinical anal intraepithelial neoplasia (AIN) in patients with anal condylomata. Dis Colon rectum 2001;44:A24
13. Sobhani I, Walker F, Roudot-Thorval F, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS 2004;18:1561-9
14. Goldstone SE, Kawalek AZ, Huyett MS, et al. Infrared coagulator™: a useful tool for treating anal squamous intraepithelial neoplasia. Dis Colon Rectum 2005;48:1042-54
15. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquired Immune Defic Syndr Hum Retrovirol 1998;17:314-9
16. Scholefield JH, Castle MT, Watson NFS. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005;92:1133- 6
17. Lytwyn A, Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447-56
18. Nathan M, Ratnasingham U, Obeyesekera S. Safety and Efficacy of 5% Imiquimod in the Management of Anal HPV Disease: An Open Label Pilot Study. Poster No: 43. MSSVD/SSGM Spring Meeting, Oslo, May 2002
19. Fox PA, Nathan M, Francis N, et al. A Double Blind Randomised Controlled Trial of the Use of Imiquimod Cream for the Treatment of High Grade Anal Canal Intraepithelial Neoplasia (ACIN) in HIV Positive MSM (Poster 562). 23rd International Papilloma Conference 2006, Prague
20. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56
21. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991;338:657-9
22. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect dis 2002;35:1127-34
23. Chang GJ, Berry JM, Jay N, et al. Surgical treatment of high-grade anal squamous intraepithelial lesions. A prospective study. Dis Colon Rectum 2002;45:453-8
24. Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822-9
25. Mukherjee G, Muralidhar B, Bafna UD, et al. MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India. Br J Cancer 2007;96:1107-11